Group 1 - The core viewpoint of the article highlights that Sino Medical (688108) has released a positive earnings forecast for 2025, indicating significant growth in revenue and net profit [1][3] Group 2 - As of January 30, 2026, Sino Medical's stock closed at 24.33 yuan, with a trading volume of 155,900 shares and a total transaction amount of 373 million yuan [1] - On January 30, the main funds experienced a net outflow of 4.1974 million yuan, while retail funds saw a net outflow of 8.4682 million yuan [1] - The company expects its 2025 operating revenue to be between 519.4 million yuan and 526 million yuan, representing a year-on-year growth of 13% to 15% [1][3] - The forecasted net profit attributable to shareholders for 2025 is expected to be between 43 million yuan and 50 million yuan, reflecting a substantial year-on-year increase of 2,767% to 3,233% [1][3] - The net profit after deducting non-recurring gains and losses is projected to be between 30 million yuan and 35.8 million yuan, indicating a turnaround from previous losses [1][3]
股市必读:赛诺医疗(688108)预计2025年全年营业收入5.19亿元至5.26亿元